Get started
Author

Manoj P. Samant

Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
2022 · Maria C Cid, Sebastian H Unizony, et al. · Annals of the Rheumatic Diseases · 129
PDF
Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet‐induced obese and leptin‐deficient rodents
2014 · J. L. Trevaskis, C. Sun, et al. · Diabetes Obesity and Metabolism · 59
Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action
2014 · Odile E. Levy, Carolyn M. Jodka, et al. · PLoS ONE · 47
PDF
Self-Assembling, Cystine-Derived, Fused Nanotubes Based on Spirane Architecture: Design, Synthesis, and Crystal Structure of Cystinospiranes
2001 · Darshan Ranganathan, Manoj P. Samant, et al. · Journal of the American Chemical Society · 28
Ring Size of Somatostatin Analogues (ODT-8) Modulates Receptor Selectivity and Binding Affinity
2008 · Judit Erchegyi, Christy Rani R. Grace, et al. · Journal of Medicinal Chemistry · 27
Ring Size in Octreotide Amide Modulates Differently Agonist versus Antagonist Binding Affinity and Selectivity
2008 · Christy Rani R. Grace, Judit Erchegyi, et al. · Journal of Medicinal Chemistry · 23
1256MO Phase I/II ARROS-1 study of zidesamtinib (NVL-520) in ROS1 fusion-positive solid tumours
2024 · B. Besse, A.E. Drilon, et al. · Annals of Oncology · 18
PDF
Novel Analogues of Degarelix Incorporating Hydroxy-, Methoxy-, and Pegylated-Urea Moieties at Positions 3, 5, 6 and the N-Terminus. Part III
2006 · Manoj P. Samant, Doley J. Hong, et al. · Journal of Medicinal Chemistry · 17
Iterative Approach to the Discovery of Novel Degarelix Analogues: Substitutions at Positions 3, 7, and 8. Part II
2005 · Manoj P. Samant, Jozsef Gulyas, et al. · Journal of Medicinal Chemistry · 15
Structure−Activity Relationship Studies of Gonadotropin-Releasing Hormone Antagonists ContainingS-Aryl/Alkyl Norcysteines and Their Oxidized Derivatives
2007 · Manoj P. Samant, Richard White, et al. · Journal of Medicinal Chemistry · 14
Norcystine, a New Tool for the Study of the Structure−Activity Relationship of Peptides
2006 · Manoj P. Samant, Jean E. Rivier · Organic Letters · 14
Novel gonadotropin‐releasing hormone antagonists with substitutions at position 5
2004 · Manoj P. Samant, Doley J. Hong, et al. · Biopolymers · 14
PDF
PL02.15 Pivotal ARROS-1 Efficacy and Safety Data: Zidesamtinib in TKI Pre-treated Patients with Advanced/Metastatic ROS1+ NSCLC
2025 · A.E. Drilon, B.C. Cho, et al. · Journal of Thoracic Oncology · 8
First-in-Human Phase 1 Randomized Trial with the Anti-CD40 Monoclonal Antibody KPL-404: Safety, Tolerability, Receptor Occupancy, and Suppression of T-Cell–Dependent Antibody Response
2023 · Manoj Samant, John Ziemniak, et al. · Journal of Pharmacology and Experimental Therapeutics · 8
PDF
Synthesis, in vivo and in vitro biological activity of novel azaline B analogs
2005 · Manoj P. Samant, Jozsef Gulyas, et al. · Bioorganic & Medicinal Chemistry Letters · 8
Design, synthesis and membrane ion transport properties of cystine- and serine-based cyclo -4-oxa-heptane-1,7-bisamides
2002 · Darshan Ranganathan, Manoj P Samant, et al. · Tetrahedron Letters · 8
Pseudoprogression (PsP) in Patients with Peripheral T-Cell Lymphoma (PTCL) Treated with the Novel Stapled Peptide ALRN-6924, a Dual Inhibitor of MDMX and MDM2
2018 · Andrei R. Shustov, Amitkumar Mehta, et al. · Blood · 6
Abstract 11653: Prolonged Rilonacept Treatment in Rhapsody Long-Term Extension Provided Persistent Reduction of Pericarditis Recurrence Risk
2022 · Massimo Imazio, Allan L Klein, et al. · Circulation · 5
Synthesis and biological activity of GnRH antagonists modified at position 3 with 3‐(2‐methoxy‐5‐pyridyl)‐alanine*
2005 · M.P. Samant, C. Miller, et al. · Journal of Peptide Research · 5
Characterization of Multisubstituted Corticotropin Releasing Factor (CRF) Peptide Antagonists (Astressins)
2016 · Judit Erchegyi, Lixin Wang, et al. · Journal of Medicinal Chemistry · 3
Synthesis of protected norcysteines for SPPS compatible with Fmoc strategy
2007 · Manoj P. Samant, Jean E. Rivier · Tetrahedron Letters · 3
Abstract CT109: First-in-class first-in-human phase 1 trial and translational study of the mono(ADP-ribose) polymerase-7 (PARP7) inhibitor RBN-2397 in patients with selected advanced solid tumors
2023 · Timothy A. Yap, Andres Cervantes, et al. · Cancer Research · 2
Prolonged Rilonacept Treatment in RHAPSODY Long-Term Extension Provided Persistent Reduction of Pericarditis Recurrence Risk
2023 · Corina Grancorvitz, Massimo Imazio, et al. · 2
Abstract 12057: Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and mRNA Vaccinations: Experience From Phase 3 Rhapsody Long-Term Extension
2022 · antonio brucato, Lucia Trotta, et al. · Circulation · 1
Zidesamtinib efficacy and safety in patients with advanced ROS1 -positive solid tumors other than NSCLC in the ARROS-1 study.
2026 · Benjamin J. Solomon, Sanjay Popat, et al. · Journal of Clinical Oncology
Works count: 28
Citation count: 464
H-index: 12
I10-index: 12
Year
Topic
Type